BGLC · BioNexus Gene Lab Corp
United States · RS rating 9 · As of 2026-11-03
| Price | 0.95 USD |
|---|---|
| 1-day change | -5.5% |
| RS rating (overall / 1M / 3M / 12M) | 9 / 15 / 15 / 8 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 5 / 28 |
| Industry group (rank) | Chemicals-Specialty (103) |
| EPS growth Q/Q | -15.2% |
| Sales growth Q/Q | +12.6% |
| Distance from 52-week high | +82.7% |
| Market cap (USD) | $5.4M |